– Participants treated with atacicept for 72 weeks showed consistent and sustained reductions in Gd-IgA1, hematuria, and UPCR, with stable eGFR over the duration of treatment – Placebo cohort ...
Next DLP, a leader in insider risk and data protection, is debuting Secure Data Flow, a new feature of the Reveal Platform—a flexible, cloud-native, AI- and ML-powered solution built for today's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results